Á¦  ¸ñ :   CMR-WTS

CMR(Critical Mineral Ratio>¶õ - ¸ð¹ß¹Ì³×¶ö°Ë»ç°á°ú Áúº´¿¹Ãø ÁßÁõµµÀÇ °áÁ¤¿¡ ÇٽɵǴ Æ÷ÀÎÆ®. ±³°¨½Å°æÇü°ú ±³°¨½Å°æ¿ì¼¼, ºÎ±³°¨½Å°æÇü°ú ºÎ±³°¨½Å°æ¿ì¼¼´Â ´Ù¸¥ ¸»ÀÌ´Ù. ±³°¨½Å°æÇü(=ÀÌÈ­ÇüCatabolic)/ºÎ±³°¨½Å°æÇü(=µ¿È­ÇüAnabolic)Àº ½ÅüÀÇ ¿¡³ÊÁö´ë»ç À¯Çü¿¡ ´ëÇÑ ¸»À̸ç, ±³°¨½Å°æ¿ì¼¼(¸Æ¾ÐÀÌ ³ô°í È£ÈíÀÌ ºü¸£´Ù=Ã浿Àû=¼º±Þ)/ºÎ±³°¨½Å°æ¿ì¼¼(¸Æ¾ÐÀÌ ³·°í È£ÈíÀÌ ´À¸®´Ù=ÀÚÆ÷ÀÚ±â=ħüÇü)´Â ÁÖ¾îÁø ½ºÆ®·¹½º¿¡ ´ëÇÑ ¸öÀÇ ¹ÝÀÀ°ú ´õºÒ¾î °¨Á¤Àû Ãø¸é¿¡¼­ ¼º°ÝÀ¸·Î Ç¥ÃâµÇ´Â Ä¡¿ìÃļ­ ³ªÅ¸³ª´Â ¹ÝÀÀÀÇ °³³äÀÓÀ» ¸ÕÀú »ý°¢Ç϶ó. 


###Low Energy Level 3Á¶°Ç:1-2´Â ¿¡³ÊÁö»ý»êÀÌ»ó
*1)°©»ó¼±ÀÌ»ó Ca/K=over10 or under1 *2)ºÎ½ÅÀÌ»ó Na/Mg =over8 or under2 *3)low Level of both Na-K despite nornal range of Na/Mg
###´ç³»¼ºÀÌ»ó :Ca/Mg=over10 or under3.3 + Na/K inversion(under2.4)
###Displacement Çö»ó: HMT»ó ÇÑÂÊÀÌ »ó½ÂÇÏ¸é ´Ù¸¥ ÂÊÀÇ °¡»ó½Â À¯µµ: Pb->Ca Hg->Na Cd or Cu->Zn  Fe->Cr
###<»óȣų·¹ÀÌÆÃÀÇ ÀÓ»óÀûÀÇÀǸ¦ °®´Â ¿µ¾ç¹Ì³×¶ö/µ¶¼º¹Ì³×¶öºñÀ²>ÀÌ°ÍÀº µ¶¼ºÁ߱ݼÓÀÌ Á¤»óÄ¡¿¡¼­ ¹þ¾î³ª ÃàÀûµÈ »óŶó¸é »óȣų·¹ÀÌÆÃÇÏ´Â °ü°èÀÇ ¿µ¾ç¹Ì³×¶öÀÇ ±â´ÉÀÌ ½É´ëÇÑ Å¸°ÝÀ» ¹Þ¾Æ ±â´É°áÇÌÀ» ÀÏÀ¸Å³ ¼ö ÀÖ°í, ±×±â´É ȸº¹°ú µ¶¼ºÁ߱ݼÓÀÇ Á¦°Å´Â »ýüȰ¼ºÇüÀÎ ¿µ¾ç¹Ì³×¶öÀ» ¿ÜºÎ¿¡¼­ Åõ¿©ÇØ ÁÜÀ¸·Î½á À¯µµÇÒ ¼ö ÀÖÀ½À» ÀǹÌÇÑ´Ù. Ca-Pb(Ca/Pb), Zn-Hg,Cd(Zn/Hg, Zn/Cd), Fe-Pb.Hg(Fe/Pb,Fe/Hg), Se-Hg(Se/Hg), S-Pb,Hg,Cd(S/Pb,S/Hg,S/Cd)


###Psychotic Responses
#Hill pattern :  Ca.Mg<5, Na/K>4 - positive change in life     
**dec.Ca/Mg-openness+ reduced defensiveness
**inc.Na/K : assertness and willfulness
#Bowl pattern : Ca/Mg>13, Na/K<2 -emotional rigidity
**inc.Ca/Mg : defensiveness
**dec.Na/K : indecisiveness, exhaustion, À庮°¨:1ÀÌÇÏ¿¡¼­´Â delusion, frustration, resentmenet, hostility¹ß»ý
#StepUp pattern: Ca/Mg<5, Na/K<1.5--fastOxidation.
--Great fatigue, delusion, À庮°¨
--cancer, other serious health conditions
#StepDown : Ca/Mg>13, Na/K>5--slowOxidation.
**defensiveness/sturbonness
**inc.Ca/Mg : defending one's position
**inc.Na/K : anger, assertness(´ÜÈ£¼º), willfulness
#Aggressiveness pattern : Ca<20, Mg<3, --more prominenced when Zn<10
**¾ÈÁ¤°¨°ü¿©¹Ì³×¶öÀÎCa, Mg, ZnÀÌ ¿¬ºÎÁ¶Á÷¿¡ ºÎÁ·½Ã °úµ¿°ø°Ý°ú¹Î¼ºÁõ´ë


##1.Na/K Vitality ratio»ýµ¿(»ý»çÀ²)ºñÀ² ¶Ç´Â ½ºÆ®·¹½ººñÀ² : Autonomic DominanceÀÚÀ²½Å°æ¿ì¼¼Çü = high: ±³°¨½Å°æ¿ì¼¼Çü, low : ºÎ±³°¨½Å°æ¿ì¼¼Çü, 1.5-4 :±ÕÇüÇü
(Á¤»ó2.4:1---Na´Â ¾Ëµµ½ºÅ×·Ð K´Â ÄÚƼ¼Ö ºÐºñ´ÉÀ» ÀǹÌ):Áúº´¿¡ ´ëÇÑ °ßµð´Â ÀûÀÀ ·¹º§À» ÀǹÌÇϴµ¥--Ç÷´ç, ¸é¿ª°è, ºÎ½Å, ¼ÒÈ­±â ½ÅÀå, °£ ¹× ¿¡³ÊÁöÀÇ Ã游ÇÑ Á¤µµ, Áï º´À» À̰ܳ»´Â Á¤µµ¿Í »ó°ü °¡Àå Áß¿äÇÑ ´ÜÀÏÁöÇ¥ÀÓ
#ÆÇÁ¤ --- Na/K<2.4:1ÀÏ ¶§¸¦ ¿ªÀüinversionÀ̶ó°í ÇÏ¸ç ºÎ½Å°í°¥Adrenal exhaustion, ´Ü¹éÁúºÐÇØ(ÀÌÈ­ÀÛ¿ë)Catabolism, ³»´ç´ÉÀå¾ÖCHO intolerance ¶Ç´Â ´Ù¸¥ ´ë»çÀÌ»óÀÌ Àß ¿È. ÀÌ¿Í ´õºÒ¾î Ca/MgºñÀ²ÀÌ 3.5ÀÌÇÏ·Î ¿ªÀüÀÌ µÉ ¶§¸¦ ÀÌÁß¿ªÀüDouble InversionÀ̶ó Çϴµ¥ ºü¸¥»êÈ­³ª ±¸¸®ºÒ±ÕÇü¿¡¼­ º¼ ¼ö ÀÖ´Ù.
***Na<4 mg% ¾Ëµµ½ºÅ׷аáÇÌ K<2mg% ÄÚƼ¼Ö °áÇÌ ÀÇ¹Ì Na/K°¡
<1:1(ÃÖÀú-½ÉÀå¹ßÀÛ, ¾Ï¹ß»ý, ´Ü¹éÁúºÐÇØ, ¸¸¼º½ºÆ®·¹½ºÃÖ°íÁ¶) extreme inversion
1:1-2;1(ÁßÀú-´ç´¢º´,¸é¿ª°èÀÌ»ó,°üÀý¿°,ÇÇ·Î,±Ë¾ç, ¼ÒÈ­Àå¾Ö, °£ ½ÅÀ彺Ʈ·¹½º) moderate inversion
2:1-2.4:1(°æÀú-ºÎ½Å¾àÈ­, ³»´ç´ÉÀÌ»ó, ÀúÀ§»êÁõ) mild inversion
2.4-4:1(ÃÖ»óÀÇ ±ÕÇü)-- Æ÷µµ´ç°ú ź¼öÈ­¹°ÀÇ ¿¡³ÊÁö ÀüȯÀÌ °¡Àå ÁÁÀ½ balanced
4:1-8:1(°æ°í-¿°Áõ, ±Þ¼º ½ºÆ®·¹½º ÁöÇ¥) mild high
>8:1(±Þ¼º½ºÆ®·¹½º, ¿°Áõ, °£ ½ÅÀå ½ºÆ®·¹½º)
#ó¹æ
1)ÇÏ°­½Ã ºñÀ² »ó½ÂÀ§ÇØ - ´ë°³ ´À¸°´ë»ç¿¡¼­ ³ªÅ¸³²
*ºñŸ¹ÎBcompB5B6CE *¹Ì³×¶ö:Cu.Mn.Cr.Mo.Fe *½ÄÀÌ: ´çºÐ55%·Î ÁÙÀÌ°í, 10%ÀÇ Á¦ÇÑµÈ Áö¹æ, 35%ÀÇ °í´Ü¹éÁú½ÄÀÌ°¡ ÇÊ¿ä *»ýÈ°½À°ü Á¶Àý: ¸¸¼º½ºÆ®·¹½º, °¥µî, ±äÀå, ÀÌÁß¼Ó¹Ú, ¿øÇÑ, °áÁ¤Áþ±â ¾î·Á¿ò µî°ú °ü°èµÊ
2)Áö³ªÄ£ »ó½Â½Ã ÇÏ°­À§ÇØ - ´ë°³ ºü¸¥ ´ë»ç¿¡¼­ ³ªÅ¸³²
*ºñŸ¹Î:Äݸ°,À̳ë½ÃÅç,A *¹Ì³×¶ö:Zn, Mg **´À¸°´ë»ç¿¡¼­´Â Kµµ µµ¿òµÊ(¸¶±×³×½·Æ÷Ÿ½·¾Æ½ºÆĸ£Å×ÀÌÆ® ÇüÅÂ) *½ÄÀÌ:Â¥Áö¾Ê°Ô *»ýÈ°½À°ü : ±Þ°ÝÇÑ ½ºÆ®·¹½º³ª ºÐ³ë¹ßÀÛ°ú »ó°üµÊ


##2.¿¡³ÊÁö´ë»çºñÀ² ¶Ç´Â »êÈ­ºñÀ²Oxidation rate(½Åü´ë»ç À¯Çü : Metabolism type -Ca/K°©»ó¼±ºñÀ² + Na/MgºÎ½ÅºñÀ²)
#ÆÇÁ¤: °¢°¢ÀÇ °æ¿ì ¸ðµÎ¿¡¼­ 1:1ÀÌÇϸ¦ ÃÖÀú 1:1-2:1À» ÁßÀú 2:1-4:1À» °æÀú, 4:1-8:1À» °æ°í 8:1-16:1À» Áß°í 16:1ÀÌ»óÀ» ÃÖ°í·Î ³ª´©°í, 4:1¿¡¼­ ¸Ö¼ö·Ï ½ÉÇÏ´Ù°í ÆÇÁ¤.
1.Ca/K<4:1 Na/Mg>4:1 ºü¸¥´ë»ç=±â´ÉÇ×Áø, ºü¸¥»êÈ­Çü-mild(°æµµ) moderate(Áߵ) extreme(°íµµ)À¸·Î ³ª´® --Ca<40 Mg<6 Na>24 K>10À» º¸ÀÓ
#temporary fast oxidation(ÀÏ°ú¼º ºü¸¥»êÈ­)-high4 Áï, Na>24 K>10 À̸鼭 µ¿½Ã¿¡ Ca>40 Mg>6
=high4= slow under stress(´À¸°»êÈ­ÇüÀε¥ ToxinÃàÀû or ½ºÆ®·¹½º »óŸ¦ÀǹÌ) **À̶§Ca/K<4 Na/Mg>4ÀÓ-B1356CEhighZn,modCa,modMg  cf)Âü°í: Low4(±¸¸®´Â ´ë°³ »ó½Â) =adrenal burnout-´ë°³ fast oxidizer :highCa100-1800, highMg800-900, Zn50-75(Na/K<2.4->¹ÝÀ¸·Î ÁÖ¶ó):Èí¼öÀå¾Ö ÀÖ´ÂÁö º¸¶ó..
#Fast oxidation with inversion(¿ªÀü»óÅÂÀÇ ºü¸¥»êÈ­) :Ca/K<4 Na/Mg>4, µ¿½Ã¿¡ Na/K<2.4:1
2.Ca/K>4;1 Na/Mg<4;1 ´À¸°´ë»ç=±â´ÉÀúÇÏ, ´À¸°»êÈ­Çü- mild moderate extreme
3.Mixed OxidationÈ¥ÇÕÇü »êÈ­ :Ca/K³ª Na/Mg ¾î´ÀÂÊÇϳª°¡ ºü¸¥ ´ë»çÀÌ¸é ´À¸°´ë»ç ÆÐÅÏ, ´À¸° ´ë»ç¸é ºü¸¥ ´ë»ç ÆÐÅÏÀ» º¸À̴°Í- ºü¸¥´ë»ç2Çü ¶Ç´Â ´À¸°´ë»ç3Çü[=Ca/K>4(°©Àú) and Na/Mg>4(ºÎÇ×)] À̰ųª ºü¸¥´ë»ç3Çü ¶Ç´Â ´À¸°´ë»ç2Çü[=Ca/K<4 (°©Ç×)and Na/Mg<4(ºÎÀú)] --- ¾î´ÀÂÊÀÌ ´õ extreme¿¡ °¡±î¿î°¡¿¡ µû¶ó fast-mixed, or slow-mixed oxidation À¸·Î °áÁ¤, Áï °©Ç×-ºÎÀú¿¡¼­ °©Ç×ÀÌ ´õ¼¼¸é(=extrem¿¡ ´õ °¡±î¿ì¸é) ºü¸¥´ë»ç3Çü, ºÎÀú°¡ ´õ¼¼¸é ´À¸°´ë»ç2ÇüÀ¸·Î °áÁ¤ÇÏ¿© ó¹æ.
#ó¹æ
1)´À¸°´ë»çÀÇ °æ¿ì -*ºñŸ¹Î : BCcoQSeCr *¹Ì³×¶ö:K,(Zn-CuCd»ó½Â½Ã)FeMnCr, °áÇÌÁõ»ó µ¿¹Ý½Ã CaMgÃß°¡ *½ÄÀÌ(ź-Áö-´Ü=55-10-35 : °í´Ü¹é35%(¼ø»ì°í±â-°ß°ú·ù/µÎºÎµî Äá·ù20%-Èò»ì»ý¼±10%) ¾çÁúÀÇ Áö¹æ10%(Âü±â¸§ ¿Ã¸®ºêÀ¯ Æ÷µµ¾¾À¯ ¾Æ¸¶À¯ À¯Ã¤±â¸§ µî) º¹ÇÕź¼öÈ­¹°55%(Çö¹Ì/Åë¹Ð/Àâ°î¹ä30%, ³ìÁó/ÇØÃÊ Æ÷ÇÔ ¾ßä20%, °í±¸¸¶-¸¶´Ã-¾çÆÄ-ºÎÃß-½Ã±ÝÄ¡-´ç±Ù-±è, °úÀÏ5%)---*»ýÈ°½À°ü : ½ÄÀü¿¡ ´ÙÀ̾îÆ®Äݶó(¾Æ½ºÆÄŽÀÌ ÇÔÀ¯: °£-½É-½ÅÀ» ±ú¿ì°í ´ë»çÇ×Áø½ÃÅ°¸ç À§»êºÐºñ¸¦ ÃËÁø½ÃÅ´)³ª Â÷(¹ÐÅ©Ä¿ÇÇ<¿øµÎÄ¿ÇÇ<³ìÂ÷<»ý°­-°¨ÃÊ-´ëÃßÂ÷:¾Æħ Á¡½É¸¸ Çã¿ë)-´çÈ­Áö¼ö ³·Àº dzºÎÇÑ ¾ßä-°úÀÏ»ø·¯µå-T3, ¿îµ¿À» ½ºÆ®·¹ÄªÀ¸·ÎºÎÅÍ ½ÃÀÛÇÏ¿© Á¡Á¡ ´Ã·Á ³ª°£´Ù.., ÃæºÐÇÑ È޽İú ¼ö¸é ÇÊ¿ä, ´í½º°¡ ÁÁ°í ±ÙÀ°ÀÌ ¹¶Ä¥Á¤µµÀÇ °úµµÇÑ ¿îµ¿Àº ±ÝÁö ***Ÿ¿ì¸°-±Û·çŸ¹Î- ¿¤Ä«¸£´Ïƾ-BCAA-¼¿·»-Å©·Ò-ÄÚÅ¥10´Â ¸ðµç ´ë»ç¿¡ °øÈ÷ ÇÊ¿ä.
2)ºü¸¥´ë»çÀÇ °æ¿ì -*ºñŸ¹Î;W3(ceSeBiotinB6)D Äݸ° À̳ë½ÃÅç *¹Ì³×¶ö : ZnCaCuMg *½ÄÀÌ(ź-Áö-´Ü=35-40-25 : ¾çÁúÀÇ Áö¹æ40%·Î Áõ·®(¸ÅÀÏ 1-2½ºÇ¬ÀÇ Âü±â¸§+°è¶õ ¸¶½Ã±â, µ¿¹°¼ºÆ÷È­Áö¹æÀºÃÑ¿­·®ÀÇ8%À̳», °ß°ú·ù+ÂüÄ¡¾Æ´Ñ µîǪ¸¥»ý¼±, Çô³ú°£½É½ÅÀåÀÇ ³»ÀåÀ°, °Ô-°¡Àç-±¼-»õ¿ì-Á¶°³ µî Ç»¸°ÇÔ·®À» Áõ·®)´Ü¹éÁú25% Åº¼öÈ­¹°35%·Î °¨·® ---- *»ýÈ°½À°ü : ºñŸ¹ÎA-¾Æ½ºÆÄŽ ±ÝÁö, Ä«ÆäÀÎÀ» ¿Ã¸®´Â Ä¿Çdzª ´Ù¸¥ ±³°¨½Å°æÈïºÐÁ¦¸¦ ±ÝÇÒ°Í, ¿ÀÈ÷·Á °ú´ÙÇÑ ¿îµ¿»óŸ¦ À¯ÁöÇÏ°í ÀÖ´Â °æ¿ì°¡ ¸¹À¸¹Ç·Î Áß°£ Á¤µµÀÇ ¿îµ¿À¸·Î ÁÙÀÌ°í ¸í»ó-hot bath°¡ ÁÁ´Ù.   ***WTSÀ¯¹ß±âÀü: ½ºÆ®·¹½º¿¡ ´ëóÇϱâ À§ÇÑ ¿¡³ÊÁö ¿ä±¸°¡ Áõ°¡ÇÒ ¶§ ¸ÕÀú À¯¹ßµÇ´Â ºÎ½ÅÄÚƼÁ¹ »ó½ÂÀº óÀ½¿£ Ç÷´çÀ» ¿Ã¸®±âÀ§ÇÑ Å»¾Æ¹Ì³ë-´ç½Å»ý°úÁ¤À» À§ÇØ ½ºÅ×·ÎÀ̵åÈ£¸£¸ó°áÇÕ´Ü¹é ¹× °©»ó¼±È£¸£¸ó°áÇմܹéÀ» ºÐÇØ ÀÌ¿ëÇÏ°í, ¶ÇÇÑ ¿¡³ÊÁö ¿ä±¸¿¡ ºÎÀÀÇϱâ À§ÇØ ½Ã»óÇϺÎTRH-³úÇϼöüTSH¹æÃâÀÌ ´Ã¾î³²À¸·Î½á °á±¹ FT4»ó½Â-->È°¼ºÇüÀÎ FT3»ó½ÂÇÏ°Ô ÇÏÁö¸¸ Á¶±Ý Áö³ª¸é ÄÚƼÁ¹ÀÛ¿ë¿¡ ÀÇÇØ FT4-->ºñÈ°¼ºÇüÀ̸鼭 FT3ÀÛ¿ëÀ» ¾ïÁ¦ÇÏ¸ç ±× Á¦°Å¼Óµµ°¡ ¸Å¿ì ´õµò rT3ÂÊÀ¸·ÎÀÇ ÀüȯÀÌ ´õ ¿ì¼¼ÇÏ°Ô µÇ°í FT3´Â ÀüȯÀÌ ¶³¾îÁö°Ô µÇ¸ç °á±¹ ³ªÁß¿¡ ºÎ½Å°ú °©»ó¼±ÀÌ Á¤»óÈ­ µÇ´õ¶óµµ FT3 ´Â ³·°í rT3´Â ¿ÀÈ÷·Á ³ôÀº WTS »óŸ¦ À¯¹ßÇÒ ¼ö ÀÖ´Ù. Ã¼¿Â1CÀúÇϽà ´ë»çÀ²ÀÌ10% °¨¼ÒÇÑ´Ù.  ###¿Âµµº¯¹ý(³·ÀºÂÊÀº 1.8À» °öÇÏ°í ³ôÀºÂÊÀº ³ª´«´Ù)--¼·¾¾¸¦ È­¾¾·Î : (¼·¾¾ + 40) * 1.8 - 40 ---È­¾¾¸¦ ¼·¾¾·Î : (È­¾¾ + 40)/ 1.8 - 40
#WTSÁø´Ü :°æ±¸¿ÂµµBBTÃøÁ¤=(»ý¸®Àü3ÀÏ Á¦¿ÜÇÑ ³¯µ¿¾È), ±â»ó½Ã¿Í ±×ÈÄ 3½Ã°£°£°ÝÀ¸·Î 2¹ø, ¶Ç´Â ±â»óÈÄ3½Ã°£ °£°ÝÀ¸·Î 3¹ø 2-3ÀÏ°£ ÃøÁ¤ÇÑ ±¸°­ ¿Âµµ (º¸Åë3ºÐµ¿¾È °ÅÄ¡)ÀÇ °¢ ³¯ÀÇ Æò±Õ°ªµéÀÇ  Æò±ÕÀ» º»´Ù. ±â»óÁ÷ÈÄ Æ÷ÇÔÇÏ¿© ÃÖ¼Ò ÇÏ·ç 3¹øÃøÁ¤Çϵµ·Ï ÇÑ´Ù. Á¤»óÀÇ °æ¿ì¿¡¼­´Â ±â»óÁ÷ÈÄ ±¸°­Ã¼¿ÂÀº36.25CÀÌ»óÀ̸鼭 ±â»óÈÄ3½Ã°£ °£°ÝÀ¸·Î 2ȸ ÃøÁ¤½Ã ¸ðµÎ 36.5CÀÌ»óÀÓ. ±ú¾î³­ Á÷ÈÄ ¿Âµµ°¡36.25CÀÌÇÏÀ̰ųª ±â»óÈÄ 3½Ã°£°£°ÝÀ¸·Î ÃøÁ¤ÇÑ ÃÑ3ȸ Áß Àý¹ÝÀÌ»óÀÌ 36.5'CÀÌÇÏÀ̸é WTS·Î Áø´Ü ***±â´ÉÀÇÇÐÀû Á¤»ó¹üÀ§ ÀÀ¿ë TSH: 1.2 - 2.0 µIU/mL Total T4: 6.0 - 12.0 mcg/dl Reverse T3: 14.9 - 26.1 ng/dl Free T3: 2.3 - 4.2 pg/ml Free T4: 0.7 - 2.4 ng/dl


# º¸Åë Slow Oxidizer¿¡¼­´Â hypothyroid conditionÀÌ ¸¹´Ù, ÇÏÁö¸¸ ¶§·Î WTS-like symptoms or fatigue°¡ ÀÖÀ¸¸é¼­µµ Ç÷¾×³»¿¡¼­´Â highTT4 andTT3  plus dec.TSH( 2ndary hyperthyroid condition but not 2nadary hyperthyroidism) in slow oxidizer¸¦ º¸ÀÌ´Â °æ¿ì°¡ ÀÖ´Ù - d/t dec. tissue cell mermeability(peripheral resistance d/t inc.Ca and Mg=°á±¹ ¼¼Æ÷´Â °©»ó¼±±â´ÉÀúÇÏ»óÅÂ) and hyperstimulation of thyroid by sympathetic stimulation9°úÀ׿), stress(±Ù½É°ÆÁ¤), ¶Ç´ÂCu or Hg toxicity( hidden or evident == Cu, Hg ÃàÀûÀº °©»ó¼±È£¸£¸óÀÇ °úÀ×»ý»êÀ̳ª ¾ïÁ¦ ¾ç ¹æÇâÀ¸·Î ÀÛ¿ëÇÒ ¼ö ÀÖ´Ù) ¶§¹®ÀÌ´Ù.


##3.Glucose tolerance ratio ´ç³»¼ººñÀ² ¶Ç´Â Glucose Sensitivity Ratio´ç¹Î°¨ºñÀ²(Ca/Mg)
- ½Ä´Ü ÁßÀÇ Åº¼öÈ­¹° ¾ç°ú ±×°ÍÀ» ÀûÀýÇÏ°Ô ÀÌ¿ëÇÏ´Â ¸öÀÇ ´É·Â. ºñÀ²ÀÌ ³ô´Ù¸é °íCHO½Ä´Ü »óÅÂÀÓÀ» ÀǹÌ. - CaÀº Àν¶¸° »ý»êÀ» ÃËÁø, MgÀº ¾ïÁ¦½ÃÅ´
#ÆÇÁ¤ :
1)Ca/Mg=7ÀÌ Á¤»óÀ¸·Î 3.5-10;1 Á¤µµ¸¦ ÀÌ»óÀûÀÎ Á¶Àý´É·Â¹üÀ§·Î º¸¸ç 3.5ÀÌÇÏÀ̸é ÀúÇ÷´ç¼º(°øº¹ÀúÇ÷´ç), 10ÀÌ»óÀÌ¸é °íÇ÷´ç¼ºÀν¶¸°ÀúÇ×¼º(½ÄÈÄÇÇ°ï°¨)À» ³ªÅ¸³»¸ç 3ÀÌÇÏÀ̰ųª 12ÀÌ»óÀÌ¸é ¸Å¿ì ½ÉÇÑÁ¤µµ·Î¼­ ´ç´¢º´ÀÇ ÀÌȯÀ²ÀÌ ³ô¾ÆÁø´Ù. ƯÈ÷ ÀÌ¿Í ´õºÒ¾î Na/K°¡ 2:1ÀÌÇÏ·Î ¿ªÀüµÇ¸é ÀÌÁß¿ªÀüÀ¸·Î¼­ ´ç´¢º´ÀÇ °¡´É¼ºÀº ´õ Áõ´ëµÈ´Ù.
2)K<4(ÄÚƼ¼Ö ºÐºñ °áÇÌ), Ca/K>20ÀÏ ¶§µµ ´ç´¢º´À¯¹ß°¡´É¼ºÀÌ ³ô´Ù. ÀÌ¿Í ÇÔ²² MnZnCrÀÌ °áÇ̵ǰųª Áö³ªÄ¡°Ô ³ô¾Æµµ DM °¡´É¼ºÀÌ Áõ´ëµÈ´Ù. FeCuPbCd µîÀÌ ½×ÀÏ ¶§µµ ³»´ç´ÉÀå¾Ö°¡ ¿Â´Ù.
#ÀúÇ÷´çÁõÀÌ ³ªÅ¸³ª´Â °æ¿ì - ÀúÇ÷´çÁõÀº Ç÷´ç¼öÄ¡°¡ ¾Æ´Ñ ¼¼Æ÷³»ÀúÇ÷´ç ±× ÀÚü¸¦ ÀǹÌ(°áÄÚ Ç÷Áß Æ÷µµ´çÀÇ ³óµµ°¡ ¾Æ´Ô)
1)Ca/MgÀÌ 3.5:1ÀÌÇÏÀ̰ųª 10:1ÀÌ»óÀÎ °æ¿ì¿¡ Àß ¿Â´Ù.--3:1ÀÌÇÏ ¶Ç´Â 12:1ÀÌ»óÀÌ¸é ´ç´¢º´ÀÌ °­·ÂÈ÷ ÀǽɵǹǷΠ¹Ýµå½Ã OGTT-IR °Ë»ç¸¦ ½ÃÇàÇ϶ó.
2)´À¸° ´ë»ç¿¡¼­ HMT»ó K°¡ ³·Àº °æ¿ì¿¡¼­´Â ÄÚƼ¼ÖºÐºñµµ ÀúÇÏµÇ°í °©»ó¼±È£¸£¸óÀÇ ¼¼Æ÷È°¼ºµµ ¶³¾îÁö¹Ç·Î ÀúÇ÷´çÁõÀÌ Àß ¿À´Âµ¥ ÀÌ°ÍÀº °í´Ü¹é½ÄÀ̸¦ ÀÚÁÖÇØ ÁÜÀ¸·Î½á ¶Ç´Â ´çÈ­Áö¼ö°¡ ³·Àº °í±¸¸¶¸¦ Á¶±Ý¾¿ ¸ÔµçÁö °ß°ú·ù³ª Äá·ù¸¦ ¼·ÃëÇÔÀ¸·Î½á ±Øº¹µÈ´Ù. ÀÌ¹Ì ´ç´¢º´ ÀÖ´Â ´À¸° ´ë»ç¿¡¼­ K°¡ ³·Àº °æ¿ì¿£ ³ô¾ÆÁø Ä®½·ÀÌ Àν¶¸°ÀÇ Æ÷µµ´çÁ¶Á÷¼¼Æ÷¸·Åõ°ú ÀÛ¿ëÀ» ¾ïÁ¦ ->´çÀÇ ¼¼Æ÷³»ÀÇ ÀÌ¿ëÀ» ¾ïÁ¦ÇÏ¿© ¼¼Æ÷ÀÇ ¿¡³ÊÁö »ý»êÀ» ¹æÇØÇϹǷΠÇ÷´çÀº ³ô¾Æµµ ÀúÇ÷´çÁõÀÌ ³ªÅ¸³ª°í Ç÷´çÁ¶Á¤Àº ¾ÈµÇ°í Àν¶¸°Àº ¶Ç ³ô¾ÆÁö´Â ¾Ç¼øȯÀÌ ¿Â´Ù. (À̶§ °£¿¡¼­ ´çÀÇ »ý¼ºÀÌ ´õ¿í Ã˹ߵÊ)
3)´À¸° ´ë»ç¿¡¼­ÀÇ ÀúÇ÷´çÁõ»ó: Ca>100mg%ÀÎ °æ¿ì(Ca/Mg>10) , Àν¶¸° »ý»êÀº Áõ´ëµÇ°í ºÎ½Å°ú °©»ó¼±ÀÇ È°¼ºÀº °¨¼ÒÇÏ¸ç ¼¼Æ÷¸·³»·ÎÀÇ Æ÷µµ´ç°ú Àν¶¸°ÀÇ À̵¿ÀÌ ÀúÇÏµÇ°Ô µÇ¾î Ç÷´ç¼öÁØÀº ³·Áö ¾ÊÀ¸³ª ÀúÇ÷´çÁõ»óÀÌ ¿À¸é¼­ ´ç´¢º´À¸·Î ÀÌȯµÈ´Ù.
4)ºü¸¥ ´ë»ç¿¡¼­ÀÇ ÀúÇ÷´çÁõ»ó(Ca/Mg<3.5) : ¼¼Æ÷³»·Î ³Ê¹« »¡¸® Ç÷ÁßÀÇ Æ÷µµ´çÀÌ Èí¼öµÇ¾î Æ÷µµ´çÀ» ¼Ò¸ðÇÔ
#Ç÷´çºÒ³»¼º(glucose intolerance=impaired glucose tolerance:IGT) °í·ÁÁ¡
***Rules
1.Na/K(2.4) Ca/Mg(6.67-7)ÀÌ Á¦ÀÏ Áß¿ä, Á¤¼º¹üÀ§¸¦ ¹þ¾î³ª´Â Á¤µµ¿Í IGT´Â ºñ·Ê
2.Ca/MgºñÁ¤»óÀº CHO½ÄÀÌ°¡ °úÇÔÀ» ½Ã»çÇϱ⵵ ÇÑ´Ù.
***Áú¹®
1.Na/K<2.5
2.Ca/Mg under3.3 or over10
3.K under 4 or Ca/K over 20
4.abnormally high or low : Cr(1.0ÀÌ Á¤»ó)Mn(0.04°¡ Á¤»ó) Zn(16-20ÀÌ Á¤»ó)
5.Cu, Fe, Pb, Cd - abnormally high
6.»êÈ­À¯Çü¿¡ µû¸¥ ½Ä´ÜÀ» Á¦´ë·Î ÁöÅ°°í Àִ°¡
#ó¹æ
1)high Ca/Mg Ratio - *ºñŸ¹Î:B6 Bcomp AlphaLipoicAcid*¹Ì³×¶ö:º¹Çչ̳׶ö¿¡ Ãß°¡·Î Cr Mn Zn *½ÄÀÌ : ź¼öÈ­¹°À» 20%À̳»·Î, ÇÊ¿äÇÏ¸é °úÀÏÁ꽺³ª °ÇÁ¶°úÀϵµ Æ÷ÇÔÇؼ­ ź¼öÈ­¹°À» ÃÖ¼ÒÈ­ ÇÒ °Í
2)low Ca/Mg Ratio - *ºñŸ¹Î:B6 CE *¹Ì³×¶ö:Mg Cu


##4. Copper(Cu±¸¸®)ºÒ±ÕÇü - ÇÇ·Î Á¤¼­Àå¾Ö, ¿ì¿ïÁõ, Ä­µð´Ù°¨¿°Áõ À¯¹ß, ¹«¾ùº¸´Ù ¿¡½ºÆ®·ÎÁ¨ ¿ì¼¼Áõ À¯¹ß
: °úµµÇÑ ±¸¸®¼ººÐ ¶Ç´Â »ýüÀÌ¿ë ¾ÈµÇ´Â ¼ººÐÀ» ÀǹÌ, »ýüÀÌ¿ë ±¸¸®¼ººÐÀº ceruloplasminÀ̳ª metallothionineµîÀÇ ´Ü¹éÁú°ú °áÇÕÇÑ ¼ººÐÀ¸·Î¼­ °áÇÕµÇÁö ¾ÊÀº ³ª¸ÓÁö´Â »ç¿ëµÇÁö ¾Ê°í µ¶¼º°ú °áÇÌÁõÀ» À¯¹ß½ÃŲ´Ù. ´ë°³ ´À¸° ´ë»ç¿¡ ¸¹Àºµ¥ À̶§ HMT»ó Naµµ ³·°í Ç÷Áß ¿¡½ºÆ®·ÎÁ¨ÀÌ ³·Àº ¿©ÀÚ¿¡ ´õ ÈçÇÏ´Ù.
#´Ü¼øÇÑ ±¸¸®Áßµ¶ÁõÀÇ ±âÁØ:>3.5mg%
#hidden Cu imbalace(toxicity)ÀÇ ±âÁØ
1)´À¸°´ë»ç¿¡¼­ Cu<1.0mg% >5mg%**ºü¸¥´ë»ç¿¡¼­´Â °áÇÌÁõÀÓ
2)Zn/Cu<6:1 or >12:1(Á¤»óÀº 8:1)
3)Ca>(70)100mg%
4)K<3(6)mg%
5)Ca/K>12(8):1
6)Na/K<2.4(2.5):1(inversion)
7)Hg toxicity(>0.05mg%)
# ó¹æ: ó¹æ:´À¸°´ë»ç³Ä ºü¸¥´ë»ç³Ä¿¡ µû¶ó ÁÖµÈ ¹æÇâÀ» Á¤ÇÏ°í °úÇÏÁö ¾ÊÀº ¿îµ¿À» ½ÃÀÛ, , ¼öÀº¿¡ ´ëÇØ ¼¿·¹´½À», Na/K¿ªÀü¿¡ ´ëÇØ ºñŸ¹ÎFaB5E, C-Ȳ-Mo-Äݸ°/À̳ë½ÃÅç(Cu ų·¹ÀÌÅÍ)¸¦, Bcom-Cu±æÇ×Á¦ÀÎ Zn-Mn, ´õºÒ¾î bioavailable Ä®½·-¸¶±×³×½·-Æ÷Ÿ½·, ±¸¸®(ƯÈ÷ Na/K°¡ ³·À»¶§ Åõ¿©Ç϶ó- Ceruloplasmin »ý»êÀÚ±Ø), ¾Æ¿¬À» °ø±ÞÇÑ´Ù
** ´À¸°»êÈ­¿¡¼­ ºÎ½ÅÇÇ·Î °á°ú ´Ü¹é»ý¼ºÀúÇÏ ¿À¸é ´õºÒ¾î Á¦µ¶ÀÛ¿ë ÀúÇÏµÈ °£¿¡¼­ ceruloplasmin»ý¼º ¾ïÁ¦-ÃàÀûµÈ CuÁ¦°Å ºÒ´É):biounavailable or unbound Cu Á¶Á÷³» °ú´Ù--°£¿¡¼­ ¿¡½ºÆ®·ÎÁ¨ ´ë»ç Â÷´Ü--Estrogen dominanceÀ¯¹ß :PMS, °úÀ׿ù°æÅë, ¹«¿ù°æ, ÀڱñÙÁ¾, ³­¼Ò³¶Á¾, Ä­µð´ÙÁú¿°, Àڱ󻸷Áõ, À¯»ê, ¾Æħ¿ÀÁ¶, ÀÓ½ÅÁõµ¶Áõ, »êÈÄ¿ì¿ïÁõ
cf>***PMS with highNa/K-high Cu(Estrogen-dominant PMS--obese, º×°í ¿¹¹Î: ÃÊÄÚ·¿±ÝÁö, Cu ³·Ãß´Â Ä¡·á+Progesteron!!!) ***Progesteron dominant PMS with low Na/K+high biounavailable Cu(ÇÇ·Î, º¹ºÎÆظ¸,¿ì¿ïÁõ-ÃÊÄÚ·¿,CEB5, Mn, supplemental Cu+adrenal suppoter)
** ÇÑÆí ºü¸¥ ´ë»ç¿¡¼­´Â bioavailable Cu °áÇÌ-ºÎÁ·ÁõÀ¯¹ß)
***Cu imbalance(=biounavailable Cu ̈˞)
*¿øÀÎ :1)À°Ã¼Àû Á¤¼­Àû ½ºÆ®·¹½º-->NaÁõ°¡->Zn °¨¼Ò, CuÁõ°¡ 2)ÇÇÀÓÁ¦, IUD 3)´À¸°»êÈ­, ºÎ½ÅÇÇ·Î 4)¾Æ¿¬°áÇÌ 5)ä½ÄÁÖÀÇÀÚ ½Ä´ÜÀÇ Æ¯¼º(low Zn-high Cu) 6)Cd PbÃàÀû- dec.Zn 7)¼±ÃµÀû-¾ö¸¶·ÎºÎÅÍ ¿Â´Ù.


##Zn(ºÎÁ·½Ã P°¨¼Ò-´Ü¹éÇÕ¼ºÀå¾Ö) deficiency=male impotence with Zn deficiency +low energy
1.Zn<12
2.Cu>3.5 + Zn/cu<6
3.Cd>0.002
4.P<12
5.high or low Na/K, Cu or Cd toxicity - impotence or prostate problem
:acute prostatitis- high Na/k
: chr. prostatitis, prostCa-low Na/K


##Renal Stress(=HBP, stones, dysfunction) 4 indicators
1. Na/K : under1 over8
2.Cd(HBP À¯¹ß), Hg, Ni ÃàÀû -°¨¿°, °á¼®, ¿äÅë, ±â´ÉÀÌ»ó À¯¹ß
3.high Ca/Mg - Ä®½· °á¼® À¯¹ß(1À̳ª 2¿Í °âÇÒ ¶§ ƯÈ÷)-B6+MgÃß°¡ ÇÊ¿ä..
4.´ç´¢º´ + ÀÌÁß¿ªÀü


##¸é¿ªÃ¼°èÀÌ»ó°ú °¨¿°, ¾Ï, Áø±Õ, ¸¸¼ºÇÇ·Î EBV, AIDS, ´Ù¸¥ ¹ÙÀÌ·¯½ºÁúȯ
1.low Na/K- inversion, (+Ca/Mg inversion:double inversion) - Hg, CdÃàÀûÀº low Na¸¦ Masking..(µû¶ó¼­ À̵éÀÌ ÃàÀû½Ã, Á¤»ó Na/K¶ó¸é ÀÏ´Ü low Na/K¸¦ °¡Á¤Ç϶ó-ƯÈ÷ ¾Ï °°Àº ¸¸¼ºÁúȯ½Ã¿¡ ´õ ±×·¸´Ù.). ¾àÁ¦¸¦ ¾²°í ÀÖÀ» ¶§¿¡µµ ¿¡·¯°¡ »ý±ä´Ù. ÀÌ ¶§ Ca/Mg¿ªÀüÀÌ ÀÖ´Ù¸é hidden Na/K¸¦ µ¿¹ÝÇÑ ÀÌÁß¿ªÀü °¡´É¼ºÀ» ¿°µÎ¿¡ µÑ°Í. Ca/Mg±³Á¤ÈÄ¿¡ Na/K¿ªÀüÀÌ ºñ·Î¼Ò µå·¯³¯ ¼öµµ ÀÖ´Ù.
2.Toxic  metals--ƯÈ÷ CdÀÌ Áß¿ä : Zn´ë»ç Â÷´ÜÇÏ¿© ¸é¿ªÀ» °áÇ̽ÃŲ´Ù.
3.Cu --1ÀÌÇÏ, 10ÀÌ»óÀÏ ¶§--¸é¿ª°áÇÌ ½Ã»ç. Cu°úÀ×Àº Zn´ë»ç Â÷´Ü+ºñŸ¹ÎC »êÈ­ ÃËÁø
4.low Energy - Very slow »êÈ­+low Na/K -- ¸é¿ª¾àÈ­ À¯¹ß
5.´ç³»¼º -low Na/K imbalanced(extrem.high or extrem low) Ca/Mg -- cancer¶§ INS Ä¡·á´Â ¸é¿ª°è¸¦ °­È­ ½Ãų ¼ö ÀÖ´Ù.
6.CFS(¸¸¼ºÇÇ·ÎÁõÈıº) and AIDS : chr.EBV, AIDS, CFS --10±×·¥ ÀÌ»ó ºñŸ¹ÎC, 15¸¸ ´ÜÀ§(ÀÌÁß5000´ÜÀ§´Â ¼ö¿ë¼ºÀ¸·Î Åõ¿©) ÀÌ»óÀÇ ºñŸ¹ÎA,  40 Á¤ ÀÌ»óÀÇ Limcomin Åõ¿© ÈÄ ÁÙ¿©³ª°¨..°©»ó¼±±â´ÉÀúÇϽà caroteneÀº ºñŸ¹ÎA·Î Àüȯ ¾ÈµÈ´Ù.


 (Ca/P)°ñÁúÀ²=ÀüÇüÀûÀÎ FM type1À̳ª SM type1ÀÇ ´ë»ç ÆÐÅÏ¿¡¼­ ¹þ¾î³­ ¼Ò°ßµéÀ» ³ªÅ¸³¾ ¶§ FM or SMÀÇ Àü¹ÝÀûÀÎ ½Åü´ë»çÀ²ÀÇ ÆÇ´Ü ±Ù°Å·Î »ïÀ½=Metabolism½Åü´ë»çÀ² ---low: Catabolic(FM pattern:Sympathetic type=fight-and-flight system, accelerator Pedal, tearing-down of body==Catabolic È£¸£¸ó(NE, Epi, Cortisol, °©»ó¼±È£¸£¸ó) Ç×Áø °á°ú), --high: Anabolic(SM pattern : Parasympathetic type=Nourishing, healing Brake==Anabolic È£¸£¸ó(Àν¶¸°-³²¼º>¿©¼ºÈ£¸£¸ó, ¿À·º½Å, ºÎ°©»ó¼±È£¸£¸ó µî) Ç×Áø °á°ú)  **Ca/P>2.6-SM Ca/P<2.6 -FM
#incCa/decP-°ñ´Ù°øÁõ,°á¼®(½ÅÀå/ÄáÆÏ),³¶Á¾(°£/½ÅÀå/ÃéÀå/À¯¹æ/³­¼Ò),¿ì¿ïÁõ(Á¶Á÷³»¿¡¼­ 100mg%ÀÌ»ó½Ã-AnaCare°Ë»ç ¼öÄ¡·Î´Â 1000ÀÌ»óÀ϶§´Â ±âÀúÇÙ¿¡ Ä®½·¸· Çü¼ºµÇ¾î ½É°¢ÇÑ »óÅ À¯¹ß-ÀÚ»ì Ã浿), ºÒ¸éÁõ, Á¤½ÅÀû ÀÌ»óÁõ¼¼, ¹«°¨°¢, µ¿¸Æ°æÈ­(Çù½ÉÁõ, ºÎÁ¤¸Æ, ½ÉºÎÀüÁõ, Áßdz), °üÀý¿°, ±ÙÀ°¿°, µÎÅë, ±Ù°æ·Ã, ¿äÅë, Á°ñ½Å°æÅë, ÆíµÎÅë, ¾îÁö·³Áõ, ¹«·Â°¨, °ñ´Ù°øÁõ(Ä®½·ÆĶ󵶽º), ¾ËÄÝÁßµ¶ °æÇâ, ±âÇü¾Æ Ãâ»ê, À¯»ê,ÇÇ·Î, ½Ä¿åÀúÇÏ, ½ÄÈÄÆظ¸°¨, º¯ºñ. °øȲÀå¾Ö, ÆíÁýÁõ, ±â¾ï/ÁýÁß°¨¼Ò, ¼ºÀÎÇü´ç´¢º´, üÁßÀúÇÏ, ÀúÇ÷¾Ð, ½ÅÀå¼Õ»ó, ºóÇ÷, ÇǺο°, ÇǺΰÇÁ¶, ÈÄ°¢»ó½Ç,
#decCa/incP- Calcium defiency Áõ»ó(±Ù°æ·Ã, °ñ´Ù°øÁõ, ¼ºÀåÀúÇØ, »ÀÀÇ ±âÇü)


(Na/K)<½ºÆ®·¹½ººñÀ²:»ý»çÀ²/»ýµ¿À²>=ANSÀÚÀ²½Å°æ¿ì¼¼Çü --ÁÖ·Î ¼±È£ÇÏ´Â °¨Á¤Àû ¹ÝÀÀÀÇ ±âÁúÇü, ¿µ¾ç°áÇÌÀ̳ª ±Ý¼Ó°úÀ׿¡ ÀÇÇؼ­µµ Ã˹ߵDZ⵵ ÇÑ´Ù.
---balanced(°Ç°­Çü) : Na/K 1.5-4ÀÏ ¶§, ---low(ºÎ±³°¨½Å°æ¿ì¼¼Çü: ÀÚÆ÷ÀÚ±â-ħü-¹«°¨µ¿Çü): Na/K<1.5, or 4-LOW pattern(Ca<40, Mg<6, Na<25, K<10) ---high(±³°¨½Å°æ¿ì¼¼Çü: Ã浿¼º-ÀÏÁßµ¶-¼º±Þ): Na/K>4, and/or K<4 
Na/K<2.4-Chr.Stress 2.4-4.0 :acceptable. >4.0-Acute stress
#incNa/decK - ¾ï¿ï°¨, ºÐ³ë, °ú¹Î¹ÝÀÀ, ±Þ¼º ½ºÆ®·¹½º, ±Þ¼º¿°Áõ ºó¹ß
#dec.Na/incK- ÇÇ·Î, ¿ì¿ï, ÀúÇ÷´ç, ´ç´¢(ź¼öÈ­¹°ºÒ³»¼º), ¾Ë·¹¸£±â,  ±Ë¾ç,  ¸é¿ªÀÌ»ó,  °£/½ÅÀåÀÇ ¸¸¼º½ºÆ®·¹½º, (1:1ÀÌÇÏ¿¡¼­)¾Ï°ú ½ÉÀ彺Ʈ·¹½º Áõ°¡


(Ca/K)°©»ó¼±ºñÀ² Ca/K>4.0-SM <4.0-FM
#inc.Ca/dec.K-°©»ó¼±±â´ÉÀúÇÏ,(+ºÎ½Å±â´ÉÀúÇÏ) °íÄÝ·¹½ºÅ×·ÑÇ÷Áõ, µ¿¸Æ°æÈ­ , Çù½ÉÁõ, ¼öÁ·³Ã°¨,¼­¸Æ,¼öÁ·Àú¸², ¿ì¿ïÁõ, ÀúÇ÷´ç, ¸¸¼ºÇÇ·Î
#dec.Ca/inc.K-°©»ó¼±±â´ÉÇ×Áø,¼öÁ·ÁøÀü, ¼öÃà±â°íÇ÷¾Ð, ºÎÁ¤¸Æ,  ºó¸Æ, ¹ßÇÑ, ¹é¹ß, °ñ´Ù°øÁõ, ¾ß°£±Ù°æ·Ã, °ñÅë, °üÀý¿°, dzġ, ÃæÄ¡, 1ÇüºÒ¸é,  ¿ù°æÅë, ¿ù°æÈÄÁõÈıº


(Na/Mg)ºÎ½ÅºñÀ² Na/Mg<4.0-SM  >4.0-FM
#incNa/decMg-¼öÃà±â°íÇ÷¾Ð, ºÎÁ¾-ÇÇ·Î, ±â¸é, ºÒ¾È, ÃÊÁ¶, ¿¹¹Î, ÁýÁ߷¾àÈ­, ºÐ³ë, ¿ì¿ï, ¹«°¨°¢, ÀÚ»ìÃ浿/°æ·Ã¹ßÀÛ, °£Áú, ÀüÀÚ°£Áõ, ºó´¢, º¯ºñ, ¾ÇÃë, ¾ËÄÝÁßµ¶, Á¡¾×³¶¿°, °üÀý¿°, À̿ϱâ°íÇ÷¾Ð, ½ÉºÎÀü, ºÎÁ¤¸Æ, ½É±Ù°æ»ö, Æ÷µµ±¸±Õ¼º¼ïÁõÈıº(TSS), ¿ù°æÀüÁõÈıº, ÀÓ½ÅÁßµ¶Áõ
#dec.Na/inc.Mg- ¸¸¼ºÇÇ·Î, ¹«±â·Â, ±â¸³¼ºÀúÇ÷¾Ð, ¼­¸Æ, ¹Ý»çÀúÇÏ,  ¾Ë·¹¸£±â, ÀúÇ÷´ç, À§»êÀúÇÏ, ¿ì¿ï(CEMgPanto)


(Ca/Mg)´ç¹Î°¨µµ/Àν¶¸°ÀúÇ׺ñÀ² Ca/Mg>14(10) <3 -- M.relax/contraction, Stone, INS resistance
#incCa/decMg-ÃʱâÀúÇ÷¾Ð, ÈıâÀ̿ϱâ°íÇ÷¾Ð, ´Ü°Í°¥¸Á,1ÇüÀúÇ÷´ç(°øº¹)-ºÎ½ÅÀúÇÏÇü, 2Çü´ç´¢, 2ÇüºÒ¸é, ¾ËÄÝÁßµ¶, ºÒ¾È, ¿ì¿ï, ÇÇ·Î, ¾ß°£±ÙÀ°°æ·ÃÅë, ºÎÁ¤¸Æ, ½É±Ù°æ»ö, ½ÉºÎÀü, °á¼®, °ñ´Ù°øÁõ, ºóÇ÷, ÇǺο°, °Ç¼ºÇǺÎ, ÈÄ°¢»ó½Ç, °Ç/ÀÎ´ë ºÎÂøºÎÀ§ Á¡¾×³¶¿°, ºó´¢/¹è´¢ ±ä±ÞÁõ, º¯ºñ
#decCa/incMg-Calcium deficiency Áõ»ó, ½ÄÈÄ ½Ä°ïÁõÇüÀÇ Àν¶¸°ÀúÇ×¼º-ºÎ½ÅÇ×ÁøÇü.


(Zn/Cu)¼ºÈ£¸£¸ó/°©»ó¼±/¸é¿ª°ü·ÃºñÀ² Zn/Cu>8-FM <8-SM -Thyr. P/E2 activity:¿¡½ºÆ®·ÎÁ¨¿ì¼¼Áõ
#inc.Zn/dec.Cu-(±¸¸®»ó´ëÀû°áÇÌ) °©»ó¼±ÀúÇÏ-½ÉÀ庴 ¹ß»ýºóµµ Áõ°¡, »ý¸®ºÒ¼ø, ºÒ¾È, ü¾×Àú·ù, À¯¹æÅë, üÁßÁõ°¡, µÎÅë, º¯ºñ, ¸é¿ªÀúÇÏ(¼¼±Õ°¨¿° Áõ´ë), ÇÇ·Î, ½Ä¿åºÎÁø, È°·ÂÀúÇÏ, ¿ì¿ï, ³Ã´ã, ¹«°ü½É, ¼³»ç, ½ÄÈÄÆظ¸°¨, ¾ß¸ÍÁõ, °¢¸·¿°, ¹Ì°¢/ÈÄ°¢ÀúÇÏ, Å»¸ð ÇǺΰÇÁ¶, ÇǺο°, â»óÄ¡À¯Áö¿¬, ´ç´¢, °£°æÈ­, ¼ºÀû¼º¼÷Áö¿¬, ¹ß±âºÎÀü
#dec.Zn/inc.Cu-°ø°Ý¼º, Àû´ë°¨, °ú´ÙÇൿ, ÆíµÎÅë, °íÇ÷¾Ð, °üÀýÅë, ¼±´ÜÇǺο°, °â»óÀûÇ÷±¸¼º ºóÇ÷, °Å½ÄÁõ, ¹Ì°¢/ÈÄ°¢¼Ò½Ç, ¿ì¿ïÁõ, »ý¸®ºÒ¼ø(¾ç±â°£Áõ°¡), ¿ù°æÀüÁõÈıº/ÀÓ½ÅÁßµ¶/»êÈÄ¿ì¿ïÁõ, ½Ã½Å°æ¹Ý ÅðÇà, º¯ºñ, üÁßÁõ°¡,  ½ÅÀ庴, °£°æÈ­, °ñ´Ù°øÁõ, °íÄÝ·¹½ºÅ×·ÑÇ÷Áõ, µ¿¸Æ°æÈ­, ´ëµ¿¸ÆÆÄ¿­, ¸é¿ªÀúÇÏ, Çã¾à, Å»¸ð, ³ëÈ­, Ãø¸¸Áõ, Àª½¼¾¾º´, ¼º¿åÀúÇÏ


(Fe/Cu)ÀûÇ÷±¸»ý¼ººñÀ² : >0.9< - Fe utility
#inc.Fe/dec.Cu-½Å°æ¿°, öºÐÁßµ¶Áõ(°£°æÈ­, °üÀý¿°), ºóÇ÷(öÀÌ¿ë °¨¼Ò), ÆíµÎÅë, Àû´ë°¨, °ú´ÙÇൿ, °ø°Ý¼º, °üÀý¿°, °íÇ÷¾Ð
#dec.Fe/inc.Cu-B12°áÇÌ, ¼ÕÅé¾àÈ­, ¸ð¹ß ½±°Ô ²÷¾îÁü, À̹ÌÁõ, ¼³¿°, ±¸³»¿°, ¸é¿ª¾àÈ­,  ±â¾ï/ÁýÁß°¨¼Ò, °©»ó¼±±â´ÉÀúÇÏ, °úÀ×Çൿ, ½Å°æ/³ú¼Õ»ó-¿ì¿ï, ÀüµÎÅë, °©»ó¼±±â´ÉÀúÇÏ, ºÎ½Å±â´ÉÀúÇÏ, Çã¾à°¨, ´ç´¢, °£°æÈ­, ½ÅÀå¿°, »ý¸®ÀüÅëÁõÁõÈıº,  ¿ù°æ°ú´Ù, üÁßÁõ°¡, º¯ºñ, °ñ´Ù°øÁõ, ÄÝ·¹½ºÅ×·ÑÁõ°¡, µ¿¸Æ°æÈ­, Ç÷°üÆÄ¿­, ¸é¿ª¾àÈ­, ³ëÈ­, ÇǺο°


http://cafe.daum.net/Chelationų·¹ÀÌ¼Ç »çÀÌÆ®

´ÙÀ½±Û : Ãßõ ´Ü¹éÁú-Áö¹æÁú½ÄÇ°
ÀÌÀü±Û : ´ç´¢º´Ä¡·áÀǽÇÁ¦-nutrition/diet